RGLS logo

Regulus Therapeutics (RGLS) Operating profit

annual operating profit:

-$50.04M-$18.93M(-60.85%)
December 31, 2024

Summary

  • As of today (May 25, 2025), RGLS annual operating income is -$50.04 million, with the most recent change of -$18.93 million (-60.85%) on December 31, 2024.
  • During the last 3 years, RGLS annual operating profit has fallen by -$22.22 million (-79.90%).
  • RGLS annual operating profit is now -601.13% below its all-time high of -$7.14 million, reached on December 31, 2011.

Performance

RGLS Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRGLSincome statement metrics

quarterly operating profit:

-$10.54M+$3.21M(+23.34%)
March 31, 2025

Summary

  • As of today (May 25, 2025), RGLS quarterly operating income is -$10.54 million, with the most recent change of +$3.21 million (+23.34%) on March 31, 2025.
  • Over the past year, RGLS quarterly operating profit has dropped by -$1.71 million (-19.40%).
  • RGLS quarterly operating profit is now -983.04% below its all-time high of -$973.00 thousand, reached on September 30, 2011.

Performance

RGLS quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRGLSincome statement metrics

TTM operating profit:

-$51.75M-$1.71M(-3.42%)
March 31, 2025

Summary

  • As of today (May 25, 2025), RGLS TTM operating income is -$51.75 million, with the most recent change of -$1.71 million (-3.42%) on March 31, 2025.
  • Over the past year, RGLS TTM operating profit has dropped by -$19.19 million (-58.92%).
  • RGLS TTM operating profit is now -5219.01% below its all-time high of -$973.00 thousand, reached on September 30, 2011.

Performance

RGLS TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRGLSincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

RGLS Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-60.9%-19.4%-58.9%
3 y3 years-79.9%-60.4%-81.0%
5 y5 years-197.3%-90.4%-163.6%

RGLS Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-79.9%at low-60.4%+30.7%-83.3%at low
5 y5-year-253.5%at low-924.1%+30.7%-265.6%at low
alltimeall time-601.1%+38.6%-983.0%+50.7%-5219.0%+36.5%

RGLS Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$10.54M(-23.3%)
-$51.75M(+3.4%)
Dec 2024
-$50.04M(+60.9%)
-$13.75M(-9.6%)
-$50.04M(+12.2%)
Sep 2024
-
-$15.21M(+24.1%)
-$44.60M(+18.9%)
Jun 2024
-
-$12.26M(+38.9%)
-$37.51M(+15.2%)
Mar 2024
-
-$8.83M(+6.3%)
-$32.57M(+4.7%)
Dec 2023
-$31.11M(+10.2%)
-$8.30M(+2.2%)
-$31.11M(+4.6%)
Sep 2023
-
-$8.13M(+11.1%)
-$29.74M(+1.9%)
Jun 2023
-
-$7.32M(-0.7%)
-$29.18M(+0.5%)
Mar 2023
-
-$7.37M(+6.3%)
-$29.04M(+2.8%)
Dec 2022
-$28.24M(+1.5%)
-$6.93M(-8.3%)
-$28.24M(-0.1%)
Sep 2022
-
-$7.56M(+5.4%)
-$28.27M(-2.9%)
Jun 2022
-
-$7.17M(+9.2%)
-$29.12M(+1.9%)
Mar 2022
-
-$6.57M(-5.6%)
-$28.59M(+2.8%)
Dec 2021
-$27.82M(+96.5%)
-$6.96M(-17.3%)
-$27.82M(+27.1%)
Sep 2021
-
-$8.42M(+26.8%)
-$21.88M(+50.3%)
Jun 2021
-
-$6.64M(+14.5%)
-$14.56M(+1.0%)
Mar 2021
-
-$5.80M(+463.5%)
-$14.42M(+1.9%)
Dec 2020
-$14.15M(-15.9%)
-$1.03M(-6.0%)
-$14.15M(-19.4%)
Sep 2020
-
-$1.09M(-83.1%)
-$17.56M(-18.2%)
Jun 2020
-
-$6.50M(+17.4%)
-$21.46M(+9.3%)
Mar 2020
-
-$5.54M(+24.8%)
-$19.63M(+16.6%)
Dec 2019
-$16.83M(-64.0%)
-$4.43M(-11.2%)
-$16.83M(-17.4%)
Sep 2019
-
-$4.99M(+7.0%)
-$20.38M(-19.3%)
Jun 2019
-
-$4.67M(+70.5%)
-$25.24M(-25.6%)
Mar 2019
-
-$2.74M(-65.7%)
-$33.92M(-27.5%)
Dec 2018
-$46.76M
-$7.98M(-19.0%)
-$46.76M(-10.9%)
Sep 2018
-
-$9.85M(-26.2%)
-$52.49M(-9.6%)
Jun 2018
-
-$13.34M(-14.4%)
-$58.05M(-12.1%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$15.58M(+13.7%)
-$66.02M(-5.9%)
Dec 2017
-$70.13M(-14.0%)
-$13.71M(-11.1%)
-$70.13M(-7.9%)
Sep 2017
-
-$15.41M(-27.7%)
-$76.17M(-4.7%)
Jun 2017
-
-$21.32M(+8.2%)
-$79.94M(+0.2%)
Mar 2017
-
-$19.69M(-0.3%)
-$79.82M(-2.1%)
Dec 2016
-$81.50M(+48.8%)
-$19.74M(+2.9%)
-$81.50M(+17.9%)
Sep 2016
-
-$19.19M(-9.4%)
-$69.12M(+9.2%)
Jun 2016
-
-$21.19M(-0.9%)
-$63.27M(+0.0%)
Mar 2016
-
-$21.38M(+190.4%)
-$63.27M(+15.5%)
Dec 2015
-$54.76M(+21.9%)
-$7.36M(-44.8%)
-$54.76M(-3.8%)
Sep 2015
-
-$13.35M(-37.0%)
-$56.93M(+3.1%)
Jun 2015
-
-$21.18M(+64.6%)
-$55.24M(+17.4%)
Mar 2015
-
-$12.87M(+35.0%)
-$47.08M(+4.8%)
Dec 2014
-$44.91M(+152.3%)
-$9.53M(-18.2%)
-$44.91M(+12.2%)
Sep 2014
-
-$11.66M(-10.4%)
-$40.04M(+28.0%)
Jun 2014
-
-$13.01M(+21.6%)
-$31.29M(+36.3%)
Mar 2014
-
-$10.71M(+129.6%)
-$22.96M(+29.0%)
Dec 2013
-$17.80M(+41.6%)
-$4.66M(+60.5%)
-$17.80M(+2.1%)
Sep 2013
-
-$2.90M(-38.0%)
-$17.44M(-3.5%)
Jun 2013
-
-$4.69M(-15.6%)
-$18.07M(+13.3%)
Mar 2013
-
-$5.55M(+29.0%)
-$15.94M(+26.8%)
Dec 2012
-$12.57M(+76.2%)
-$4.30M(+21.8%)
-$12.57M(+23.9%)
Sep 2012
-
-$3.53M(+38.1%)
-$10.15M(+33.7%)
Jun 2012
-
-$2.56M(+17.3%)
-$7.59M(+50.9%)
Mar 2012
-
-$2.18M(+16.2%)
-$5.03M(+76.5%)
Dec 2011
-$7.14M(-53.9%)
-$1.88M(+92.8%)
-$2.85M(+192.8%)
Sep 2011
-
-$973.00K
-$973.00K
Dec 2010
-$15.50M
-
-

FAQ

  • What is Regulus Therapeutics annual operating income?
  • What is the all time high annual operating profit for Regulus Therapeutics?
  • What is Regulus Therapeutics annual operating profit year-on-year change?
  • What is Regulus Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly operating profit year-on-year change?
  • What is Regulus Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Regulus Therapeutics?
  • What is Regulus Therapeutics TTM operating profit year-on-year change?

What is Regulus Therapeutics annual operating income?

The current annual operating profit of RGLS is -$50.04M

What is the all time high annual operating profit for Regulus Therapeutics?

Regulus Therapeutics all-time high annual operating income is -$7.14M

What is Regulus Therapeutics annual operating profit year-on-year change?

Over the past year, RGLS annual operating income has changed by -$18.93M (-60.85%)

What is Regulus Therapeutics quarterly operating income?

The current quarterly operating profit of RGLS is -$10.54M

What is the all time high quarterly operating profit for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly operating income is -$973.00K

What is Regulus Therapeutics quarterly operating profit year-on-year change?

Over the past year, RGLS quarterly operating income has changed by -$1.71M (-19.40%)

What is Regulus Therapeutics TTM operating income?

The current TTM operating profit of RGLS is -$51.75M

What is the all time high TTM operating profit for Regulus Therapeutics?

Regulus Therapeutics all-time high TTM operating income is -$973.00K

What is Regulus Therapeutics TTM operating profit year-on-year change?

Over the past year, RGLS TTM operating income has changed by -$19.19M (-58.92%)
On this page